Skip to main content

October 13-15, 2011 - San Francisco, CA - Hyatt Regency San Francisco

2011 Oncology Congress Program Schedule

Thursday, October 13 | Friday, October 14 | Saturday, October 15

Thursday, October 13, 2011

	Thoracic Malignancies (Fadlo R. Khuri, MD) ACPE #263-000-11-262-L01-P 3.75 Contact Hrs./.375 CEUs	Melanoma (Michael B. Atkins, MD) ACPE #263-000-11-263-L01-P .75 Contact Hrs./.075 CEUs	Gynecological Malignancies (Deborah K. Armstrong, MD) ACPE #263-000-11-265-L01-P 3.75 Contact Hrs./.375 CEUs	Supportive Care/Oncology Nursing (Barbara Murphy, MD Sheila H. Ridner PhD, RN, FAAN) ACPE #263-000-11-266-L01-P 2.5 Contact Hrs./.25 CEUs
7:00 - 8:00 AM	Registration and Continental Breakfast
8:00 - 9:00 AM	Welcome Plenary: Enhancing Patient Recruitment and Enrollment In Clinical Trials George A. Fisher Jr., MD
9:15 - 10:00 AM	Opening Remarks Track Chair Impact of Genomic Medicine on Lung Cancer Fadlo R. Khuri, MD	9:15-9:20 AM Opening Remarks Track Chair Michael B. Atkins, MD	Opening Remarks Track Chair Update on Recently Completed/ On-Going Trials in Ovarian Cancer Deborah K. Armstrong, MD	Opening Remarks Track Chair Distress as a Psychological Issue in Cancer Patients Sheila H. Ridner, PhD, RN, FAAN
		9:20-9:40 AM Early Detection and Prevention Susan Swetter, MD
		9:40-10:00 AM What's New in Adjuvant Therapy Sanjiv S. Agarwala, MD
10:00 - 10:30 AM	Break
10:30 - 11:15 AM	Molecular Pathology of Lung Cancer W. Dean Wallace, MD	10:30-10:50 AM Prognostic Heterogeneity in Patients with Stage IV Disease Michael B. Atkins, MD	Gestational Trophoblastic Disease Elizabeth Jewell, MD	Caregiver Burden and Domains of Care Karen Schumacher, RN, PhD
11:15 AM - 12:30 PM	INTERACTIVE CASE WORKSHOP Managing Complicated NSCLC Cases Martin J. Edelman, MD RX = .5 hr	10:50-11:50 AM POINT-COUNTER POINT Treatment of Stage IV Disease- Patient with BRAF Mutant Melanoma A) Immunotherapy is the First-line Treatment Mario Sznol, MD B) BRAF Inhibitor is the First-line Therapy Jeffrey Sosman, MD RX = .25 hr	11:15 AM-12:30 PM Adjuvant Therapy in Endometrial Cancer Matthew Powell, MD RX = .5 hr	11:15-11:55 AM New Drug Therapy for Depression and Anxiety John Shuster, MD
		11:50 AM- 12:10 PM Treatment of CNS Metastases Omid Hamid, MD		11:55 AM-12:30 PM Sexuality and Fertility: Talking with Your Male and Female Patients About Their Options Don S. Dizon, MD, FACP
		12:10 PM-12:30 PM PANEL DISCUSSION Michael B. Atkins, MD, Mario Sznol, MD, Jeffrey Sosman, MD and Omid Hamid, MD
12:30 - 1:30 PM	Lunch Break
1:30 - 2:15 PM	Key Issues in Surgical Advances in NSCLC Malcolm V. Brock, MD	Hematologic Malignancies Lymphoma/Multiple Myeloma Sagar Lonial, MD Opening Remarks Track Chair Optimal Induction Therapy for Myeloma Sagar Lonial, MD ACPE #263-000-11-264-L01-P 1.5 Contact Hrs./.15 CEUs RX= .25 hr	Ovarian Cancer Screening Noah D. Kauff, MD, FACOG	New Drug Therapy for Pain Barbara Murphy, MD RX= .75 hr
2:15 - 3:00 PM	Systemic Therapy for Lung Cancer Martin J. Edelman, MD RX= .75 hr	Novel Targets in Relapse Myeloma Jeffrey L. Wolf, MD Rx = .25 hr.	Cervical Cancer and HPV Vaccine Don S. Dizon, MD, FACP RX= .25 hr	The Biology of Addiction Peter Martin, MD
3:00 - 3:30 PM	Break
3:30 - 5:15 PM	3:30-4:15 PM Key Issues in Radiation Oncology Ritsuko Komaki , MD, FACR, FASTRO	Transplant and Maintenance for Myeloma - A Team Based Approach Jeffrey L. Wolf, MD	3:30-4:15 PM BRCA mutations in Ovarian Cancer Noah D. Kauff, MD, FACOG Rx = .5 hr	3:30-4:15 PM Opnoid-induced Hyperalgesia Tamara King, PhD Rx = .5 hr.
3:30 - 5:15 PM	4:15-5:15 PM PANEL DISCUSSION Fadlo R. Khuri, MD, W. Dean Wallace, MD Malcolm V. Brock, MD, Ritsuko Komaki and Martin J. Edelman, MD Rx = .5 hr		4:15-5:00 PM INTERACTIVE SESSION Critical Case Discussions Deborah K. Armstrong, MD, Elizabeth Jewell, MD, Don S. Dizon, MD, FACP , Noah D. Kauff, MD, FACOG	4:15-5:15 PM Non-pharmacologic Approaches to Depression and Anxiety Mary Ann Nihart, MA, PMHNP-BC, PMHCNS-BC Rx = .75 hr
5:30 - 6:30 PM	Networking Reception in the Exhibit Hall/Exhibits

Friday, October 14, 2011

	Breast Cancer (Debu Tripathy, MD) ACPE #263-000-11-267-L01-P 5.25 Contact Hrs./.525CEUs	Hematologic Malignancies Lymphoma/Multiple Myeloma (Sagar Lonial, MD) ACPE #263-000-11-268-L01-P 2.75 Contact Hrs./.275 CEU	Urologic Malignancies Matthew (Cooperberg, MD, MPH) ACPE #263-000-11-69-L01-P 4.5 Contact Hrs./.45 CEUs	Supportive Care/Oncology Nursing (Barbara Murphy, MD Sheila H. Ridner PhD, RN, FAAN) ACPE #263-000-11-270-L01-P .75 Contact Hrs./.075 CEUs
7:00 - 8:00 AM	Continental Breakfast
8:00 - 9:00 AM	Plenary Session: Oncology Patient Centered Medical Home: Accountable Cancer Care John D. Sprandio, MD, FACP
9:15 - 10:00 AM	9:15-9:20 AM Opening Remarks Track Chair Debu Tripathy, MD	Mantle Cell Lymphoma Rx = .25 hr	Opening Remarks Track Chair Screening and Chemo Prevention Matthew Cooperberg, MD, MPH RX= .25 hr	Incidence of Adverse Oral Outcomes in Cancer Patients Michael Brennan, MD
9:15 - 10:00 AM	9:20-10:00 AM Screening and Prevention Across the Risk Continuum Christy Russell, MD	Mantle Cell Lymphoma Rx = .25 hr
10:00 - 10:30 AM	Break/Exhibits
10:30 - 11:15 AM	Innovations in Local Therapy Ben O. Anderson, MD RX = .5 hr	10:30-11:30 AM INTERACTIVE CASE CHALLENGE T-Cell Malignancies Mary Jo Lechowicz, MD Rx = .25 hr	10:30-11:30 AM Active Surveillance Early Stage Prostate Cancer: Defining Triggers for Intervention Matthew Cooperberg, MD, MPH	Prevention of Oral Cavity Late Effects Cesar A. Migliorati, DDS, MS, PhD
11:15 AM - 12:00 PM	Molecular Decision-Making and Chemotherapy in Early Stage Breast Cancer Ruth O'Regan, MD RX = .25 hr	Management and Novel Targets in Hodgkin's Lymphoma Mary Jo Lechowicz, MD Rx = .25 hr	11:30 AM-12:30 PM Kidney Cancer Update: Novel Targeted Therapies and Surgical Interventions Lauren Harshman, MD Rx = .5 hr	Head and Neck Patients: The Effect on Swallowing and Nutrition Barbara Murphy MD
12:00-12:30 PM	INTERACTIVE TUMOR BOARD Debu Tripathy, MD, Christy Russell, MD, Ben O. Anderson, MD, Ruth O'Regan, MD Rx= .5 hr	Follicular Lymphoma Ginna G. Laport, MD Rx = .25 hr		Case Based Problem Solving Michael Brennan, MD; Cesar A. Migliorati, DDS, MS, PhD; Barbara Murphy, MD
12:30 - 1:30 PM	Lunch Break
1:30 - 2:15 PM	Hormonal Therapy and Bone Health/Survivorship Debu Tripathy, MD Rx = .5 hr	Hematologic Malignancies Leukemia (Robert S. Negrin, MD) Opening Remarks Track Chair Use of Transplantation for Treatment of Patients with Leukemia Robert S. Negrin, MD ACPE #263-000-11-271-L01P 1.75 Contact Hrs./.175 CEUs	Management of Invasive Systemic Bladder Cancer Randall Millikan, PhD, MD RX = .5 hr	Neurocognitive Dysfunction in Head and Neck Cancer Patients Stewart Bond, PhD, RN, AOCN
2:15 - 3:00 PM	Principles of HER2+ Breast Cancer Management Debu Tripathy, MD RX = .25 hr	Treatment of Acute Lymphoblastic Leukemia (ALL) in Adults Partow Kebriaei, MD RX= .75 hr	POINT-COUNTER POINT High-Risk Non-Metastatic Prostate Cancer James Eastham, MD, FACS Mack Roach III, MD , FACR RX= .25 hr	Assessment and Treatment of Dysphagia Jan Lewin, PhD RX= .25 hr
3:00 - 3:30 PM	Break/Exhibits
3:30 - 4:15 PM	The Latest Approaches for Metastatic Breast Cancer (HER2-negative) Hope S. Rugo, MD RX= .25 hr	Should we focus on overall survival or progression-free survival in follicular lymphoma? Ginna Laport, MD	(Continued) POINT-COUNTER POINT High-Risk Non-Metastatic Prostate Cancer James Eastham, MD, FACS Mack Roach III, MD , FACR RX= .25 hr	Mucositis, Mucosal Sensitivity and Taste Alterations Barbara Murphy, MD
4:15 - 5:15 PM	INTERACTIVE CASE WORKSHOP Debu Tripathy, MD, Hope S. Rugo, MD	INTERACTIVE CASE WORKSHOP Clinical Issues and Future Directions in Hematologic Malignancies: Chronic Myeloid Leukemia H. Jean Khoury, MD, FACP RX = .25 hr	QoL: Implications After Diagnosis - The Unmeasurable Variable Martin G. Sanda, MD	The Effects of Laser Light Therapy as Part of Your Treatment Tool Kit Mark M. Schubert, DDS, MSD

Saturday, October 15, 2011

	Novel Therapies Alex Adjei, MD, PhD, FACP ACPE #263-000-11-272-L01P 3.25 Contact Hrs./..25CEUs	Hematologic Malignancies Leukemia (Robert S. Negrin, MD) ACPE #263-000-11-273-L01P 3.25 Contact Hrs./.325CEUs	Gastrointestinal Cancers Richard M. Goldberg, MD ACPE #263-000-11-274-L01P 1.75 Contact Hrs./.175 CEUs	Supportive Care/ Oncology Nursing (Barbara Murphy, MD; Sheila H. Ridner PhD, RN, FAAN)
7:00 - 8:00 AM	Continental Breakfast
8:00 - 9:00 AM	Plenary Session: Mindful Living with Cancer: Improving Quality of Life Anne Coscarelli, PhD
9:15 - 10:00 AM	Opening Remarks Track Chair Toxicities of Novel Agents Alex Adjei, MD, PhD, FACP RX= .75 hr	New Concepts in Chronic Lymphoblastic Leukemia (CLL) David Miklos, MD, PhD RX= .25 hr	Opening Remarks Track Chair Multidisciplinary Management of Advanced Stage Colorectal Cancer in Aging Adults Richard M. Goldberg, MD	Introduction to Lymphedema Sheila Ridner, PhD, RN, FAAN
10:00 - 10:15 AM	Break
10:15 - 11:00 AM	Incorporating Biomarkers into Drug Development and Clinical Practice Janet Dancey, MD, FRCPC Rx = .75 hr	Treatment of Myeloproliferative Disorders Jason R. Gotlib, MD Rx = .25 hr	Neuroendocrine Tumors Emily Bergsland, MD	The Biology of Lymphedema Stan G. Rockson, MD
11:00 - 11:45 AM	Advances in Immunotherapy Nikhil I. Khushalani, MD Rx = .75 hr	CML: New Drugs in Development Neil Shah, MD, PhD Rx = .75 hr	Application of Advanced Radiotherapy Techniques for Pancreatic and Liver Tumors Albert Koong, MD	Lymphedema in Head and Neck Cancer Patients Jie Deng, PhD, RN, OCN
11:45 AM - 12:45 PM	Promising Novel Targets Patricia LoRusso, DO Rx = .5 hr	INTERACTIVE CASE WORKSHOP (Topic TBD) David Miklos, MD, PhD; Jason R. Gotlib, MD and Neil Shah, MD, PhD RX = .5 hr	Roundtable Neoadjuvant Therapy in the Management of GI Tract Cancers Andrew H. Ko, MD RX= .75 hr	Exercise and Lymphedema in Breast Cancer Patients Kathryn Schmitz, PhD, MPH
12:45 PM - 1:30 PM	PANEL DISCUSSION Alex Adjei, MD, PhD, FACP; Janet Dancey, MD, FRCPC; Patricia LoRusso, DO		Prevention, Screening, and Management: New Frontiers in Managing Gastric Cancer David H. Ilson, MD, PhD RX= .25 hr	PANEL DISCUSSION

Schedule as of June 3, 2011
RX = Pharmacology credit for Advanced Practice Clinicians
For sessions without faculty listed, invited faculty are pending